Anavex Life Sciences Corp.'s stock rises 50% as EMA reviews Alzheimer's drug blarcamesine. Click for my updated look at AVXL stock and why I have upgraded it.
LATS1/2-inactivation and consequent nuclear YAP/TAZ hyperactivation in the mammary epithelium drives the development of a pro ...
21h
News Medical on MSNRethinking red meat: Are dietary guidelines missing the bigger picture?Research highlights the critical role of red meat in providing essential nutrients like iron, zinc, and B12, particularly for ...
By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results